Warrants are being used for investors and against them. The danger is not knowing which one your company signed.
A warrant is a promise your company made to somebody else about your shares. It is the right to buy stock at a set price, for a set time, written into a contract and filed with the SEC as an exhibit. Companies raise money this way every week. Some of those contracts are fair. Some are written so that the other side wins whether the company does well or badly — and the shareholder pays either way.
Nothing found, nothing paid. See a whole report free →
Used for you
The company gets money it needs, on terms that only pay off if it succeeds.
A warrant struck above the market price costs you nothing today. It is only worth exercising if the stock rises — and if it rises, the company gets a second round of cash at that higher price. The holder and the shareholder want the same thing.
A clean warrant has a fixed price, a fixed number of shares, a fixed expiry, and no clause that changes any of them later. You can read it in five minutes.
Used against you
The other side is paid in your shares, and the contract lets them take more as the price falls.
A warrant struck at or under the market price, or one that resets lower when the stock drops, is a machine for making shares. The holder can sell into the market while the warrant covers them; the price falls; the warrant resets; more shares come out; the price falls again. It ends in a reverse split, and the shareholder who held through it owns a fraction of what they started with.
The words for that are in the exhibit — ratchet, reset, pre-funded, alternate cashless exercise, most favored nation — usually forty pages in, in language written to be skipped.
The danger is not knowing.
None of this is hidden. Every one of these contracts is public the day it is signed, on EDGAR, as an 8-K with the warrant attached as an exhibit. The problem is not secrecy. The problem is that nobody reads the exhibit — not the shareholder, not the press release, and not the headline that says the company “raised $10 million.”
So a shareholder can hold a stock for two years and never learn that:
- the price they paid was already promised away to a warrant holder at a lower one;
- the reverse split that wiped out their position was the ending of a contract signed eighteen months earlier;
- the same lender has done the same deal to a dozen other companies, and it ended the same way each time;
- the company’s own auditor said in the same filing that it may not be able to continue.
Raising money with warrants is lawful, and most of the companies that do it are ordinary companies doing an ordinary thing. Nothing on this page says any company or any person did anything wrong. It says the contract exists, it says what it permits, and it says you should know which kind you are holding before the market tells you.
That is the whole service. We read every filing the SEC publishes, exhibits included, and when one carries warrant language we record who filed it, when, and what the paper permits — in plain English, the day it lands.
A whole report, free
Open the sample report →
See exactly what you get before you type your own ticker.
Theriva Biologics (TOVX) — the full verdict as a paying reader sees it: every warrant filing, what the paper permits, who is on the other side, the going concern record, and the plain-English reading of the exhibit. Nothing held back, nothing to pay.
What do you want to know?
Warn me when it’s mine.
Leave your tickers. The day a warrant filing lands on one of them, you hear from us. Free, always.
Free, always. Never published or sold.